CA-VOXELDANCE
25.5.2021 07:14:09 CEST | Business Wire | Press release
Voxeldance , a leading provider of digital manufacturing software for additive 3D printing, today announced the appointment of Robert Yusin as Chief Operating Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210524005861/en/
Yusin will lead operations and collaborate with the executive team to drive global growth. He brings more than 25 years of global experience in manufacturing applications, security, network, storage, and cloud in software and hardware. He was formerly one of three founders at Oqton. He also served as Director of Sales/business development at Autodesk where he pioneered the Asia market for the Autodesk Consumer Group (ACG) division. His previous experience includes executive roles at Accelops (Fortinet), Trustwave, Symantec, Loglogic (TIBCO), McAfee, and StorageTek. Yusin has built and managed companies and functions from zero to $300+ million in revenue.
“Robert brings a tremendous record of success and I am excited to add him to the company’s executive team,” said Zhang Chaoxin, CEO of Voxeldance. “His experience with startups with successful exits and domain expertise in manufacturing will help Voxeldance expand operations to support the next phase of growth.”
“Voxeldance offers software solutions that will integrate with the end-to-end digital factory for customers and partners,” said Robert Yusin. “The leadership team has built a great company as evidenced by the portfolio of large enterprise customers and partners; I look forward to contributing to the team.”
Additional Resources:
Official website: https://www.voxeldance.com
Video site: https://www.youtube.com/channel/UC1d6KPoLhTjwREMPRuG2MFg?view_as=subscriber
Twitter: https://twitter.com/VoxelDance
Facebook: https://www.facebook.com/VoxelDance-666723630455229/
WeChat Public Number: VoxelDance
LinkedIn: http://www.linkedin.com/company/Voxeldance
Customer case studies and evaluations: https://voxeldance.com/blog
Sales inquiry: info@voxeldance.com
About Voxeldance:
Voxeldance is the recognized leader for manufacturing software solutions for additive 3D printing, with a high adoption rate in use with hardware technology partners and service bureaus that integrate Voxeldance flagship additive software with their solutions. Voxeldance products are secure, cost effective and are easily adaptable to integrate with existing technology for the digital factory. The software products are built on technology advancements that will proactively accelerate workflow processes allowing the operator to effectively streamline hours of time for operational improvements in supporting many vertical use cases. Voxeldance is headquartered in Shanghai China and can be found online at http://www.voxeldance.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210524005861/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Newmont Announces Key Executive Appointments for the Next Phase of Delivery15.6.2026 23:20:00 CEST | Press release
Newmont Corporation (NYSE: NEM, ASX: NEM, PNGX: NEM) (“Newmont”) today announced leadership appointments that further shape its go-forward Executive Leadership Team under President and Chief Executive Officer Natascha Viljoen and reflect the depth of leadership talent within the company. Effective July 1, 2026, Brian Tabolt has been appointed Chief Financial Officer, Mark Rodgers has been appointed Chief Operating Officer, and David Thornton has been appointed Chief Technical Officer. In addition, David Fry has been promoted to Executive Vice President, Project Development, reflecting the importance of disciplined project development and execution as Newmont advances its highest-return growth opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615487768/en/ Mark Rodgers - COO “These appointments bring together respected leaders with deep industry experience and a strong understanding of our operational, financia
Westlake Expands Global Chlorovinyls Manufacturing Capacity With Acquisition of PVC and VCM Plants in Wilhelmshaven, Germany15.6.2026 20:18:00 CEST | Press release
Westlake Corporation (NYSE: WLK) (“Westlake”) announced today that its German subsidiary, Westlake Vinnolit GmbH & Co. KG, has completed the previously-announced acquisition of a polyvinyl chloride and vinyl chloride monomer production site located in Wilhelmshaven, Germany (the “Wilhelmshaven plant”). The Wilhelmshaven plant, which was previously in insolvency administration, has the capacity to produce 380,000 metric tons of PVC per year. “This acquisition strengthens our Performance & Essential Materials business by expanding our global chlorovinyls manufacturing footprint and complements our existing chlorovinyl production facilities in Europe and North America,” said Jean-Marc Gilson, President and Chief Executive Officer of Westlake. “The Wilhelmshaven plant, which is located in Lower Saxony on Germany’s North Sea coast, benefits from advantageous logistical infrastructure, including a deep-water dock that enables efficient raw-materials supply. We look forward to welcoming the s
Onera Announces Integration of the Onera hPSG® Solution With Somnoware15.6.2026 19:35:00 CEST | Press release
Onera hPSG®, an end-to-end home polysomnography solution from Onera Health, is now integrated into Somnoware, enabling their customers to conduct Polysomnography tests (PSGs) in the patient's home while managing the entire workflow in Somnoware. Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, now integrates with Somnoware by ResMed sleep lab management software. This integration enables clinicians to conduct Polysomnography tests (PSGs) where patients sleep most comfortably, in their own home, while managing the entire workflow in Somnoware. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615106079/en/ Onera hPSG®, an end-to-end home polysomnography solution from Onera Health, is now integrated into Somnoware, enabling their shared customers to conduct Polysomnography tests (PSGs) in the patient's home while managing the entire wo
Digital Cooperation Organization Launches Global Expert Community to Accelerate International Digital Cooperation15.6.2026 18:18:00 CEST | Press release
A global platform mobilizing expertise and collective action to advance shared digital priorities The Digital Cooperation Organization (DCO), the world's first standalone international organization dedicated to inclusive and sustainable digital economy growth, today announced the launch of the Global Expert Community (GEC) — a new platform designed to mobilize expertise and advance international collaboration in support of high-impact digital initiatives across DCO Member States and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615565781/en/ Digital Cooperation Organization Launches Global Expert Community to Accelerate International Digital Cooperation (Graphic: AETOSWire) The GEC reflects the DCO's continued commitment to turning digital cooperation into action by expanding access to specialized expertise and strengthening collaboration across sectors and borders. As digital transformation reshapes economies an
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 115.6.2026 18:00:00 CEST | Press release
- Secondary and Exploratory Endpoint Results from Phase 3 Studies Presented at SLEEP 2026 Underscore Improvements with Oveporexton Across a Broad Range of Daytime and Nighttime Symptoms - Takeda is on Track to Bring the First and Only Orexin Agonist to People Living with Narcolepsy Type 1 with Regulatory Submissions Under Review Takeda (TSE:4502/NYSE:TAK)today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective agonist, improved daily functioning as well as cognitive and sleep-related symptoms associated with narcolepsy type 1 (NT1).1,2,3 Oveporexton is designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. These data, along with previously disclosed Phase 3 results, demonstrated improvement across the broad disease spectrum, supporting the potential of oveporexton to redefine the standard of care for NT1.4 "Narcolepsy type 1 is a 24-hour disease drive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom